Bispecific Antibody Therapy for Treating Relapsed and Refractory Multiple Myeloma
Dana-Farber Cancer Institute via YouTube
Launch a New Career with Certificates from Google, IBM & Microsoft
Build the Finance Skills That Lead to Promotions — Not Just Certificates
Overview
Google, IBM & Meta Certificates — All 10,000+ Courses at 40% Off
One annual plan covers every course and certificate on Coursera. 40% off for a limited time.
Get Full Access
Explore a comprehensive medical lecture where Dr. Shonali Midha from Dana-Farber Cancer Institute examines the emerging role and therapeutic potential of bispecific antibodies in treating relapsed/refractory multiple myeloma, providing valuable insights into this innovative treatment approach for healthcare professionals and researchers in the field of hematologic oncology.
Syllabus
Bispecific Antibody Therapy in Multiple Myeloma
Taught by
Dana-Farber Cancer Institute